Specialists in biomolecules
Bioibérica researches, develops, manufactures and markets the main chondroprotective molecules for treating osteoarthritis: chondroitin sulphate, glucosamine and hyaluronic acid.. They are chondroprotector drugs (term that means, literally: cartilage protector medicines). These are medicines with a slow symptomatic action (SYSADOA) that act directly on the three structures of the joint affected by the osteoarthritis: the joint cartilage, synovial membrane and subchondral bone. Several studies endorse chondroprotectors for their high efficacy, safety and cost.
WE WILL BE PLEASED TO HELP